Cargando…

Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis

BACKGROUND: Presence of subretinal abscess in endogenous endophthalmitis indicates a more severe form of infection. Available reports indicate variable response to standard treatment with systemic, intravitreal pharmacotherapy and vitreous surgery. There are no reports citing the possible role of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatesh, Pradeep, Temkar, Shreys, Tripathy, Koushik, Chawla, Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088442/
https://www.ncbi.nlm.nih.gov/pubmed/27847635
http://dx.doi.org/10.1186/s40942-016-0043-x
_version_ 1782464096393756672
author Venkatesh, Pradeep
Temkar, Shreys
Tripathy, Koushik
Chawla, Rohan
author_facet Venkatesh, Pradeep
Temkar, Shreys
Tripathy, Koushik
Chawla, Rohan
author_sort Venkatesh, Pradeep
collection PubMed
description BACKGROUND: Presence of subretinal abscess in endogenous endophthalmitis indicates a more severe form of infection. Available reports indicate variable response to standard treatment with systemic, intravitreal pharmacotherapy and vitreous surgery. There are no reports citing the possible role of intralesional antibiotic therapy in managing subretinal abscess. CASE PRESENTATION: A 30 year old lady presented with features of endogenous endophthalmitis and subretinal abscess. Presenting vision was finger counting close to face. Despite prompt initiation of systemic antibiotics and intravitreal injection, no response was noted. 25G pars plana vitrectomy was performed along with injection of vancomycin directly into the subretinal abscess, using a 41G needle. Postoperative course was uneventful and the abscess showed signs of rapid resolution. Visual acuity improved to 6/24. CONCLUSION: Intralesional pharmacotherapy may be safe and effective in the treatment of subretinal abscess associated with endogenous endophthalmitis.
format Online
Article
Text
id pubmed-5088442
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50884422016-11-15 Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis Venkatesh, Pradeep Temkar, Shreys Tripathy, Koushik Chawla, Rohan Int J Retina Vitreous Case Report BACKGROUND: Presence of subretinal abscess in endogenous endophthalmitis indicates a more severe form of infection. Available reports indicate variable response to standard treatment with systemic, intravitreal pharmacotherapy and vitreous surgery. There are no reports citing the possible role of intralesional antibiotic therapy in managing subretinal abscess. CASE PRESENTATION: A 30 year old lady presented with features of endogenous endophthalmitis and subretinal abscess. Presenting vision was finger counting close to face. Despite prompt initiation of systemic antibiotics and intravitreal injection, no response was noted. 25G pars plana vitrectomy was performed along with injection of vancomycin directly into the subretinal abscess, using a 41G needle. Postoperative course was uneventful and the abscess showed signs of rapid resolution. Visual acuity improved to 6/24. CONCLUSION: Intralesional pharmacotherapy may be safe and effective in the treatment of subretinal abscess associated with endogenous endophthalmitis. BioMed Central 2016-08-01 /pmc/articles/PMC5088442/ /pubmed/27847635 http://dx.doi.org/10.1186/s40942-016-0043-x Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Venkatesh, Pradeep
Temkar, Shreys
Tripathy, Koushik
Chawla, Rohan
Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis
title Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis
title_full Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis
title_fullStr Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis
title_full_unstemmed Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis
title_short Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis
title_sort intralesional antibiotic injection using 41g needle for the management of subretinal abscess in endogenous endophthalmitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088442/
https://www.ncbi.nlm.nih.gov/pubmed/27847635
http://dx.doi.org/10.1186/s40942-016-0043-x
work_keys_str_mv AT venkateshpradeep intralesionalantibioticinjectionusing41gneedleforthemanagementofsubretinalabscessinendogenousendophthalmitis
AT temkarshreys intralesionalantibioticinjectionusing41gneedleforthemanagementofsubretinalabscessinendogenousendophthalmitis
AT tripathykoushik intralesionalantibioticinjectionusing41gneedleforthemanagementofsubretinalabscessinendogenousendophthalmitis
AT chawlarohan intralesionalantibioticinjectionusing41gneedleforthemanagementofsubretinalabscessinendogenousendophthalmitis